# Igenomix USA

Igenomix USA is a Biotechnology Laboratory based in Miami, United States.

## Overview

- **Organization type:** Biotechnology Laboratory
- **Headquarters:** Miami, United States
- **Region:** North America
- **Address:** Miami, FL, United States
- **Founded:** 2011
- **Assets under management:** Undisclosed
- **Website:** igenomix.com
- **LinkedIn:** https://www.linkedin.com/company/igenomix-usa

## Regulatory record

- **Reports private funds:** No

## About

Igenomix USA operates out of Miami, Florida, as part of a broader international network of genetic testing laboratories. The parent entity, Igenomix, was founded in 2011 in Spain by Dr. Carlos Simón, a leading figure in reproductive medicine, and has expanded to over 20 countries. The US arm provides preimplantation genetic testing (PGT) services, including aneuploidy screening, monogenic disorder detection, and chromosomal structural rearrangement analysis, to fertility clinics and academic institutions. The firm's core business involves genetic analysis of embryos and reproductive health diagnostics, serving the assisted reproductive technology (ART) sector. It does not publicly disclose deployment figures, investment strategies, or asset class allocations, as its operations are service-based rather than capital deployment. The firm's geographic footprint includes the US market, with additional labs in Europe, Latin America, and Asia forming a global network. No recent operational events are publicly verifiable for Igenomix USA as of mid-2026. The firm does not report AUM, team size, or professional staff publicly. It operates without disclosed philanthropic or adjacent investment vehicles, and its structure appears as a limited liability company subsidiary within the broader Igenomix corporate structure. Igenomix USA's structural differentiator is its role as a service provider in a specialized medical niche, rather than a capital allocator. It generates revenue through laboratory testing fees, not investment returns. This operational model distinguishes it from family offices or asset managers, and its primary competitive moat lies in the intellectual property and regulatory approvals held by its parent group in reproductive genetics.

## Questions

### What services does Igenomix USA offer?

Igenomix USA provides preimplantation genetic testing (PGT) for aneuploidy, monogenic disorders, and chromosomal structural rearrangements, as well as reproductive genetic diagnostics such as carrier screening and non-invasive prenatal testing. These services are delivered to IVF clinics and patients through a CLIA-certified laboratory in Miami.

### Who founded the parent company Igenomix?

Igenomix was founded in 2011 in Valencia, Spain, by Dr. Carlos Simón, a professor and researcher in reproductive medicine and genetics. The company has since expanded through acquisitions and organic growth to operate in over 20 countries.

### Where is Igenomix USA's laboratory located?

The US laboratory is located in Miami, Florida. The firm also operates testing facilities in multiple countries including Spain, Brazil, India, Japan, and the United Kingdom as part of the global Igenomix network.

### Does Igenomix publish AUM or financial metrics?

No. As a private service company, Igenomix does not publicly disclose AUM, revenue, or profit figures. Its ownership structure and financial performance are not available in public records.

## Related profiles

- [Diversified Fall Protection](https://altss.com/profile/diversified-fall-protection)
- [National Institute on Drug Abuse](https://altss.com/profile/national-institute-on-drug-abuse)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/igenomix-usa

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology